<DOC>
	<DOC>NCT01237821</DOC>
	<brief_summary>This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne.</brief_summary>
	<brief_title>Comparing OTC Acne Treatment to Prescription Regimen</brief_title>
	<detailed_description>There are many products on the market to treat facial acne. The medication that this study will be evaluating, Benzaclin and Retin-A have been approved by the FDA and is available by prescription, Effaclar is an over the counter product. This study will hopefully recognize a treatment combination that is effective in reducing acne vulgaris in adults 18-50.</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<criteria>males and females ages 1850, mild to moderate acne vulgaris with &gt; or equal to 15 inflammatory lesions, &gt; or equal to 20 noninflammatory lesions, avoid excessive sun exposure or tanning beds throughout the study Participants who have another skin condition that will interfere with lesion counting or assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>